Dr. Brotz is a neuroscientist and and drug development expert with over 20 years of experience leading toxicology, DMPK, in-vivo pharmacology, clinical pharmacology and diagnostic groups. Most recently Dr. Brotz was Sr. Director, Development Sciences at Achaogen where he contributed to multiple programs from lead optimization through Phase 3. Prior to Achaogen, Dr. Brotz worked as head of preclinical development and as a consultant for a number of emerging companies. He is an advisor for the CLSI FAST Program and a member of the Scientific Review Board of the Alzheimer’s Drug Discovery Foundation. Dr. Brotz holds a PhD in Neuroscience from the University of Tübingen.
